Hepatology

Addiction

Questions discussed in this category

How do you evaluate and manage acute alcohol withdrawal when symptom-driven protocols are confounded/unreliable?

For instance, what do you do when patients have chronic tremors, cognitive impairment, hypertension, etc.?

3 Answers available

In what cases do you use baclofen for alcohol use disorder?

3 Answers available

How do you counsel patients on the risks vs benefits of naltrexone for alcohol use disorder with persistently elevated liver enzymes?

Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...

2 Answers available

Papers discussed in this category

Frontiers in psychiatry, 2018 Oct 08

Tailored-Dose Baclofen in the Management of Alcoholism: A Retrospective Study of 144 Outpatients Followed for 3 Years in a French General Practice.

Pharmacoepidemiology and drug safety, 2018 Sep 25

Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.

The Journal of clinical psychiatry, 2020 Aug 04

Individualized, High-Dose Baclofen for Reduction in Alcohol Intake in Persons With High Levels of Consumption.

JHEP reports : innovation in hepatology, 2024 Apr 10

Safety of naltrexone in patients with cirrhosis.

Related Topics in Hepatology